⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

August 1, 2025

Figure S12 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites

Tongtong Wu Zhicong Yang Sufan Tang Hongmei Yuan Yang Liu Haiyang Li Nan Liu Zhanwen Huang Yue Chen Zhijun Zhou

View Full Paper

Ask AI

Bookmark

Share

Key Points

Micro-PET/CT imaging effectively visualizes 68Ga-labelled ligands in U87MG tumor-bearing mice.
Tumors are marked clearly in the images, showing the ligands' targeting capability.
Imaging conducted at three time points: 0.5, 1, and 2 hours post-injection to assess dynamics.
This work supports the utility of radioactive ligands for targeted cancer therapies involving fibroblasts.

Implication

Micro-PET/CT imaging shows 68Ga-labelled ligands in tumor-bearing mice at multiple time points, suggesting potential for targeted therapy.

Abstract

Figure S12. Micro-PET/CT imaging of 68Ga-labelled ligands in U87MG tumor-bearing mice at 0.5,1, and 2 p.i. (tumors are marked with white arrows).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wu et al. (2025) studied this question.

synapsesocial.com/papers/689a0c72e6551bb0af8d02ad https://doi.org/10.1158/1535-7163.29759962

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S13 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites2025
2Table S3 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites2025
3Table S5 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites2025
4Table S6 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites2025
5Table S4 from Development and Application of Radioactive Ligands Targeting Fibroblasts with Albumin-Binding Sites2025